FDA 503B outsourcing facilities in Oklahoma
Oklahoma has 2 FDA-registered 503B outsourcing facilities in the PeptideGrids directory, 1 with FDA drug recalls on record, the earliest registered in 2015. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| Qualgen LLC | Edmond | 2015 | 27 |
| Quantum Pharmaceuticals, LLC | Mounds | 2024 | None on record |
503B compounding in Oklahoma
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Oklahoma must hold the appropriate state pharmacy license. Verify any facility's current license with the Oklahoma State Board of Pharmacy.
Compounded peptides and GLP-1s
503B facilities are a primary supply route for compounded peptides and GLP-1s, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the full GLP-1 and therapeutic peptide databases, or the national directory.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Oklahoma?
2 FDA-registered 503B outsourcing facilities are listed in Oklahoma on PeptideGrids, the earliest registered in 2015.
Which Oklahoma 503B facilities have FDA recalls on record?
1 of the 2 Oklahoma facility has FDA drug recalls on record; the table above shows the count per facility.
How do I verify a pharmacy license in Oklahoma?
Use the Oklahoma State Board of Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.